You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PDE4 inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer, Cetuximab, Skin Toxicity Trial in Guangzhou (Crisaborole Ointment, Cetuximab)

Recruiting
  • Metastatic Colorectal Cancer
  • +2 more
  • Guangzhou, Guangdong, China
    WeiWei Xiao
Nov 3, 2023

Cerebrovascular Disorders, Memory, Functional Recovery Trial in Maastricht (Roflumilast Oral Tablet)

Recruiting
  • Cerebrovascular Disorders
  • +3 more
  • Roflumilast Oral Tablet
  • Maastricht, Limburg, Netherlands
    Maastricht University
Oct 25, 2021

Morphea Trial in Durham (Crisaborole)

Completed
Has Results
  • Morphea
  • Durham, North Carolina
    Duke University
Mar 10, 2021

Acne Conglobata Trial in Frankfurt (Apremilast)

Completed
  • Acne Conglobata
  • Frankfurt, Hessia, Germany
    University Hospital Frankfurt
Mar 1, 2022

Discoid Lupus Erythematosus Trial in New York (CC-10004)

Completed
Has Results
  • Discoid Lupus Erythematosus
  • New York, New York
    New York University Tisch Hospital
Feb 10, 2021

Seborrheic Dermatitis, Papulopustular Rosacea Trial in New York (PF-07038124, Placebo Ointment)

Recruiting
  • Seborrheic Dermatitis
  • Papulopustular Rosacea
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Aug 22, 2023

Parkinson Disease, Dyskinesia, Medication-Induced Trial in Lublin, Warszawa, Oswiecim (CPL500036 - low dose, CPL500036 - high

Recruiting
  • Parkinson Disease
  • Dyskinesia, Medication-Induced
  • CPL500036 - low dose
  • +2 more
  • Lublin, Lubelskie, Poland
  • +3 more
May 9, 2022

MDD Trial in Shibeen Elkom (Roflumilast 250Mcg Tab, Placebo)

Recruiting
  • Major Depressive Disorder
  • Roflumilast 500Mcg Tab
  • Placebo
  • Shibeen Elkom, Menoufia, Egypt
    Faculty of Pharmacy
Jan 16, 2023

Erectile Dysfunction Trial in Saint Petersburg (PDE5 inhibitor (tadalafil) and BTL-6000 fSWT, PDE5 inhibitor (tadalafil))

Recruiting
  • Erectile Dysfunction
  • PDE5 inhibitor (tadalafil) and BTL-6000 fSWT
  • PDE5 inhibitor (tadalafil)
  • Saint Petersburg, Russian Federation
    SBPSU
Apr 10, 2023

Behçet's Disease Trial in Beijing (Hemay005, Placebo)

Recruiting
  • Behçet's Disease
  • Beijing, Beijing, China
    Peking University People's Hospital
Nov 17, 2023

Dementia Trial in Maastricht (roflumilast (EU: Daxas, USA: Daliresp), Placebo, roflumilast)

Completed
  • Dementia
  • roflumilast (EU: Daxas, USA: Daliresp)
  • +2 more
  • Maastricht, Limburg, Netherlands
    Maastricht University, Faculty of Psychology and Neuroscience
Dec 30, 2019

Depression Trial run by the National Institute of Mental Health (NIMH) (18F-PF-06445974)

Recruiting
  • Depression
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 3, 2023

Schizophrenia Trial in Hungary, Poland (CPL500036 - low dose, CPL500036 - high dose, Placebo)

Recruiting
  • Schizophrenia
  • CPL500036 - low dose
  • +2 more
  • Budapest, Hungary
  • +7 more
May 4, 2022

Erectile Dysfunction Trial in Surabaya (Li-ESWT, Tadalafil 2.5Mg Tab)

Completed
  • Erectile Dysfunction
  • Li-ESWT
  • Tadalafil 2.5Mg Tab
  • Surabaya, Jawa Timur, Indonesia
    dr. Soetomo General Hospital
Sep 9, 2021

Asthma Trial in Sacramento (Roflumilast, Placebo)

Recruiting
  • Asthma
  • Sacramento, California
    UC Davis
Jan 31, 2022

COPD, Pulmonary Hypertension, Dyspnea Trial in United States (Tadalafil, Placebo)

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease
  • +2 more
  • Aurora, Colorado
  • +4 more
Jul 14, 2023

Estrogen-receptor-positive Breast Cancer, HER2/Neu-Negative Breast Cancer, Advanced Breast Cancerv Trial in Chicago

Not yet recruiting
  • Estrogen-receptor-positive Breast Cancer
  • +3 more
  • elacestrant, palbociclib, abemaciclib, ribociclib
  • Chicago, Illinois
    Northwestern University
Sep 25, 2023

Neuromyelitis Optica Spectrum Disorder, NMOSD, AQP4+ NMOSD Trial

Not yet recruiting
  • Neuromyelitis Optica Spectrum Disorder
  • +2 more
    • (no location specified)
    Jul 21, 2023

    Breast Cancer Metastatic Cancer Trial in Shanghai (Fluzoparib, Dalpiciclib, Fulvestrant/AI)

    Recruiting
    • Breast Cancer Metastatic Cancer
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Feb 26, 2023

    Time in Range Trial in Cairo (Dipeptidyl peptidase-4 inhibitors)

    Completed
    • Time in Range
    • Dipeptidyl peptidase-4 inhibitors
    • Cairo, Egypt
      Nancy Elbarbary
    Aug 26, 2023

    Advanced Breast Cancer Trial in Lebanon (Fulvestrant, Neratinib, Alpelisib)

    Not yet recruiting
    • Advanced Breast Cancer
    • Lebanon, New Hampshire
      Dartmouth Hitchcock Medical Center
    Jun 28, 2023

    Rheumatoid Arthritis Trial (Baricitinib 4 MG, Placebo)

    Not yet recruiting
    • Rheumatoid Arthritis
    • Baricitinib 4 MG
    • Placebo
    • (no location specified)
    Jul 27, 2023

    Healthy Volunteers Trial (Brensocatib, Clarithromycin)

    Not yet recruiting
    • Healthy Volunteers
    • (no location specified)
    Jul 19, 2023

    Nasopharyngeal Carcinoma Trial in Guangzhou (Dalpiciclib Isetionate Tablets, Camrelizumab)

    Recruiting
    • Nasopharyngeal Carcinoma
    • Dalpiciclib Isetionate Tablets, Camrelizumab
    • Guangzhou, Guangdong, China
      Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
    Feb 2, 2023

    Gastrointestinal Tumor Trial in Hangzhou (Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T,

    Completed
    • Gastrointestinal Tumor
    • Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T, Germany)
    • tislelizumab (BeiGene, China) combined with PD-1 inhibitor
    • Hangzhou, China
      Zhejiang Hospital
    Sep 1, 2023